Skip to main content
Signal8

CytomX Therapeutics, Inc. (CTMX)

CytomX Therapeutics, Inc. is a United States-based biopharmaceutical company primarily focused on creating treatments for cancer. The company utilizes its proprietary Probody technology platform to engineer targeted antibody therapeutics for oncological applications. Its robust clinical pipeline includes several notable drug candidates. CX-2009, an antibody-drug conjugate (ADC) designed to target CD166, is currently in Phase II clinical trials for treating breast cancer. Another investigational therapy, CX-2029, has also reached Phase II trials, where it is being evaluated for various cancers such as squamous non-small cell lung cancer, head and neck squamous cell carcinoma, esophageal and gastro-esophageal junction cancers, and diffuse large B-cell lymphoma. Additionally, CytomX is progressing two CTLA-4 Probody therapeutics: BMS-986249, which is undergoing Phase I/II clinical trials for metastatic melanoma, and BMS-986288, in Phase I trials for solid tumors. Beyond these, the company is developing CX-2043, a conditionally activated ADC targeting the epithelial cell adhesion molecule, and CX-904, a conditionally activated epidermal growth factor receptor, both aimed at addressing solid tumor conditions. CytomX has forged strategic partnerships with leading pharmaceutical firms, including AbbVie Ireland Unlimited Company, Amgen, Inc., Bristol-Myers Squibb Company, ImmunoGen, Inc., Pfizer Inc., and Astellas Pharma Inc., to collaboratively advance its Probody therapeutics. The company was founded in 2008 and its main office is located in South San Francisco, California.

Sector: Pharmaceutical Preparations

Industry: Biotechnology

CytomX Therapeutics, Inc. logo

CytomX Therapeutics, Inc.

NASDAQ:CTMXHealthcare
+2.18%$2.34
AH$2.38+1.71%vs close
Mkt Cap$509.88M
Float200.29M
O/S217.9M
Vol
$ Vol
RVOL
Inst Own98.4%
SI21.4%
Earnings
Dilution
Financials Summary
Revenue$76.2M
Net Income-$17.37M
Total Assets$151.57M
Free Cash Flow-$75.81M
Debt & Equity
Debt 4%
Equity 96%
Total Debt$4.24M
Total Equity$99.01M
Shares Outstanding
Short Interest
Split History

No splits on record

Nothing in CTMX's public trading history: no forward or reverse split has affected the share count.

Balance Sheet Details
Assets$151.57M
Liabilities$52.56M
Accounts Receivable$2.01M
Accounts Payable$1.3M
Inventory$0
PP&E (Net)$4.7M
Goodwill$949K
Intangible Assets$438K
Income Statement
PeriodFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016FY 2015FY 2014FY 2013
CurrencyUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Period Ending2025-12-312024-12-312023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-31
Revenue$76.2M$138.1M$101.21M$53.16M$37.31M$68.43M$57.49M$59.5M$71.62M$15.04M$7.71M$5.08M$888K
YoY Growth-44.8%36.4%90.4%42.5%-45.5%19.0%-3.4%-16.9%376.1%95.1%51.9%471.7%-
Cost of Revenue$0$0$0$0$0$0$0$0$0$0$0$0$0
Gross Profit$76.2M$138.1M$101.21M$53.16M$37.31M$68.43M$57.49M$59.5M$71.62M$15.04M$7.71M$5.08M$888K
Gross Margin100.0%100.0%100.0%100.0%100.0%100.0%100.0%100.0%100.0%100.0%100.0%100.0%100.0%
Research and Development$68.73M$83.38M$77.68M$111.65M$114.19M$112.94M$131.62M$103.87M$92.28M$54.76M$28.36M$28.3M$10.89M
Selling, General, and Administrative$29.84M$29.73M$30.02M$42.85M$39.16M$36.03M$36.77M$33.51M$25.61M$19.87M$12.56M$6.54M$4.95M
Other$0$0$0$0$0$0-$135K-$68K-$27K-$69K$0-$55K$71K
Total Operating Expenses$98.56M$113.11M$107.7M$154.5M$153.35M$148.97M$168.38M$137.38M$117.88M$74.63M$40.91M$34.84M$15.84M
Operating Income (EBIT)-$22.36M$25M-$6.48M-$101.33M-$116.04M-$80.54M-$110.89M-$77.87M-$46.26M-$59.59M-$33.2M-$29.77M-$14.96M
Operating Margin-29.3%18.1%-6.4%-190.6%-311.0%-117.7%-192.9%-130.9%-64.6%-396.1%-430.5%-586.3%-1684.2%
Interest Expense$0$0$0$0$0$0$0$0$0$1.69M$1.73M$487K$254K
Interest Income$5.21M$7.14M$9.84M$1.68M$255K$1.84M$8.37M$7.64M$2.67M$2.42M$1.31M$7K$6K
Other Income (Expense)$5.23M$7.1M$9.81M$2.02M$172K$29.63M$8.23M$7.57M$2.65M$667K-$2.16M-$535K-$177K
Income Before Tax (EBT)-$17.13M$32.09M$3.32M-$99.32M-$115.87M-$50.91M-$102.67M-$70.3M-$43.61M-$58.92M-$35.36M-$30.3M-$15.13M
Income Tax Expense$238K$224K$3.89M$0$0$13.91M-$427K$14.3M-$513K-$19K$10K$10K$10K
Net Income-$17.37M$31.87M-$569K-$99.32M-$115.87M-$64.82M-$102.24M-$84.6M-$43.1M-$58.9M-$35.37M-$30.31M-$15.14M
Net Income Margin-22.8%23.1%-0.6%-186.8%-310.5%-94.7%-177.8%-142.2%-60.2%-391.5%-458.7%-597.0%-1705.3%
Supplementary Data
EPS-0.150.38-0.01-1.48-1.26-0.71-2.26-2.03-1.16-1.63-1.00-0.87-15.32
Diluted EPS-0.150.38-0.01-1.48-1.26-0.71-2.26-2.03-1.16-1.63-1.00-0.87-15.32
Weighted Average OS137.94M84.44M73.81M65.74M64.15M46.15M45.34M41.66M37.17M36.23M35.48M34.92M988,511
EBITDA-$15.75M$33.86M$5.5M-$96.87M-$113.16M-$77.97M-$100.06M-$75.99M-$41.97M-$57.85M-$32.43M-$29.03M-$14.22M
EBITDA Margin-20.7%24.5%5.4%-182.2%-303.3%-113.9%-174.1%-127.7%-58.6%-384.6%-420.5%-571.8%-1601.8%
Balance Sheet
PeriodFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016FY 2015FY 2014FY 2013
CurrencyUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Period Ending2025-12-312024-12-312023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-31
Assets
Current Assets
Cash and Cash Equivalents$12.67M$38.05M$17.17M$193.65M$205.53M$191.86M$188.43M$247.58M$177.55M$104.64M$59.82M$64.4M$8.7M
Short-Term Investments$124.39M$62.57M$157.34M$0$99.7M$124.26M$107.72M$188.55M$196.56M$77.29M$126.89M$0$0
Cash and Short-Term Investments$137.05M$100.62M$174.51M$193.65M$305.23M$316.12M$296.14M$436.13M$374.11M$181.94M$186.71M$64.4M$8.7M
Accounts Receivable$2.01M$3.1M$3.43M$35.99M$790K$798K$13K$97K$10.14M$2.31M$744K$1.88M$237K
Inventory$0$0$0$0$0$0$0$0$0$0$0$100K$100K
Other Current Assets$4.86M$3.58M$5M$7.47M$0$0$0$9.25M$4.35M$0$2.3M$100K$100K
Total Current Assets$143.92M$107.31M$182.94M$237.1M$310.3M$324.01M$303.33M$445.48M$388.6M$188.15M$189.75M$66.85M$9.27M
Long-Term Assets
Property, Plant & Equipment Net$4.7M$10.6M$16.18M$21.02M$25.32M$29.45M$32.75M$6.93M$4.22M$4.39M$3.48M$3.02M$2.07M
Goodwill$949K$949K$949K$949K$949K$949K$949K$949K$949K$949K$949K$949K$949K
Intangible Assets$438K$583K$729K$875K$1.02M$1.17M$1.31M$1.46M$1.6M$1.75M$1.75M$1.75M$1.75M
Long-Term Investments$0$0$0$0$0$0$0$917K$917K$0$995K$0$0
Deferred Tax Assets$0$0$0$0$0$0$0$1.14M$398K$0$401K$0$0
Other Long-Term Assets$1.56M$1.09M$1M$944K$1.82M$3.09M$2.93M$238K$957K$3.89M-$115K$492K$148K
Total Long-Term Assets$7.64M$13.23M$18.86M$23.79M$29.11M$34.65M$37.95M$11.63M$9.04M$10.98M$7.46M$6.21M$4.92M
Other Assets$0$0$0$0$0$0$0$0$0$0$0$0$0
Total Assets$151.57M$120.53M$201.79M$260.89M$339.41M$358.66M$341.28M$457.11M$397.64M$199.13M$197.22M$73.06M$14.18M
Liabilities
Current Liabilities
Accounts Payable$1.3M$1.09M$1.46M$2.81M$2.82M$3M$4.16M$5.13M$4.21M$6.6M$4.7M$1.92M$930K
Short-Term Debt$4.24M$0$0$0$0$0$0$0$0$0$0$1.42M$1.26M
Current Income Tax Payable$0$0$0$0$0$0$0$13.34M$0$0$0$0$0
Current Unearned Revenue$26.88M$67.2M$132.27M$121.27M$40.82M$42.06M$51.38M$52.71M$40.56M$20.35M$6.13M$6.13M$857K
Other Current Liabilities$5.99M$0$9.44M$0$0$0$0$20.14M$11.86M$4.85M$2.07M$836K$405K
Total Current Liabilities$46.62M$85.77M$155.91M$152.61M$77.87M$68.11M$85.59M$97.91M$61.15M$35.77M$15.74M$11.16M$4.17M
Long-Term Liabilities
Long-Term Debt$0$0$0$0$0$0$0$0$0$0$0$1.57M$2.94M
Long-Term Unearned Revenue$1.59M$26.86M$80.05M$180.06M$243.94M$276.65M$178.86M$225.27M$264.7M$83.8M$54.7M$60.83M$4.64M
Long-Term Deferred Tax Liabilities$0$0$0$0$0$0$0$1.14M$398K$513K$507K$499K$491K
Other Long-Term Liabilities$4.35M$4.12M$3.89M$0$0$0$850K$3.05M$1.9M$566K$198K$77.54M$46.21M
Total Long-Term Liabilities$5.94M$35.22M$93.33M$194.03M$262M$298.33M$204.58M$228.32M$266.6M$84.88M$55.41M$140.44M$54.29M
Other Liabilities$0$0$0$0$0$0$0$0$0$0$0$0$0
Total Liabilities$52.56M$120.99M$249.24M$346.64M$339.87M$366.44M$290.17M$326.23M$327.75M$120.65M$71.15M$151.6M$58.46M
Stockholders' Equity
Preferred Stock$0$0$0$0$0$0$0$0$0$0$0$76.9M$44.86M
Common Stock$2K$1K$1K$1K$1K$1K$1K$1K$1K$1K$1K$1K$1K
Retained Earnings-$711.95M-$691.58M-$723.45M-$722.88M-$623.56M-$507.69M-$417.23M-$314.98M-$219.47M-$176.37M-$117.47M-$78.14M-$43.88M
Comprehensive Income & Other$111K$27K$95K$10K-$242K-$47K$57K-$93K-$94K-$27K-$76K-$404K-$399K
Other Stockholders' Equity$810.96M$691.12M$676M$637.13M$623.1M$499.92M$468.34M$445.86M$289.36M$254.84M$243.53M-$404K-$399K
Total Equity$99.01M-$456K-$47.45M-$85.75M-$459K-$7.77M$51.11M$130.88M$69.9M$78.48M$126.07M-$78.54M-$44.28M
Minority Interest$0$0$0$0$0$0$0$0$0$0$0$0$0
Total Liabilities and Equity$151.57M$120.53M$201.79M$260.89M$339.41M$358.66M$341.28M$457.11M$397.64M$199.13M$197.22M$73.06M$14.18M
Supplementary Data
Total Debt$4.24M$9.38M$13.97M$18.06M$21.67M$24.87M$27.68M$0$0$0$0$2.99M$4.2M
Net Debt-$8.43M-$28.67M-$3.2M-$175.59M-$183.86M-$166.99M-$160.74M-$247.58M-$177.55M-$104.64M-$59.82M-$61.41M-$4.5M
Cash Flow Statement
PeriodFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016FY 2015FY 2014FY 2013
CurrencyUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Period Ending2025-12-312024-12-312023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-31
Operating Activities
Net Income-$17.37M$31.87M-$569K-$99.32M-$83.61M-$32.88M-$132.82M-$84.6M-$43.1M-$58.9M-$35.37M-$30.31M-$15.14M
Depreciation & Amortization$1.38M$1.77M$2.17M$2.44M$2.71M$2.57M$2.6M$1.88M$1.65M$1.73M$1.21M$783K$655K
Deferred Income Tax$0$0$0$0$272K-$236K$0$0-$513K$6K$8K$8K$10K
Stock-Based Compensation$6.3M$7.67M$8.56M$13.13M$13.17M$14.79M$19.1M$16.88M$11.29M$10.1M$3.99M$553K$343K
Changes in Working Capital:
  Accounts Receivable$1.09M$329K$32.55M-$35.2M$8K-$785K$84K$10.04M-$7.83M-$1.57M$1.13M-$1.64M-$237K
  Inventory$0$0$0$0$11.64M-$11.12M$0$19.91M$10.32M-$253K$1.81M$188K$329K
  Accounts Payable$221K-$297K-$1.43M$68K-$139K-$857K-$374K$261K-$2.44M$1.76M$2.94M$660K$366K
  Other Working Capital-$69.89M-$126.45M-$93.64M$4.47M-$66.21M$30.89M-$31.12M-$38.2M$189.91M$43.32M-$6.13M$61.46M$5.5M
Total Working Capital Change-$68.58M-$126.42M-$62.51M-$30.65M-$54.7M$18.13M-$31.41M-$7.98M$189.97M$43.26M-$248K$60.67M$5.96M
Other Non-Cash Items$2.68M-$1.12M-$3.69M$3.62M$3.13M$2.89M$2.05M-$1.7M$11.09M$1.77M$3.01M$95K$169K
Net Cash from Operating-$75.59M-$86.23M-$56.03M-$110.79M-$119.03M$5.26M-$140.48M-$75.52M$170.37M-$2.03M-$27.41M$31.8M-$8.01M
Investing Activities
Capital Expenditures-$220K-$310K-$840K-$1.74M-$1.61M-$2.31M-$3.5M-$3.79M-$1.56M-$2.18M-$1.59M-$1.66M-$732K
Acquisitions$0$0$0$0-$24.1M$16.41M$0-$5.93M$121.27M$52K$0$0$0
Purchases of Investments-$192.52M-$155.49M-$424.83M$0-$99.9M-$199.11M-$174.99M-$204.6M-$218.71M-$121.52M-$250.9M$0$0
Sales of Investments$133M$255.5M$275M$100M$124M$182.7M$258.19M$214.31M$99M$169.5M$122.75M$0$0
Other Investing Activities$0$0$0$0$24.1M-$16.41M$0$5.93M-$121.27M$52K-$817K$0$0
Net Cash from Investing-$59.74M$99.7M-$150.67M$98.26M$22.49M-$18.72M$79.7M$5.93M-$121.27M$45.86M-$130.56M-$1.66M-$732K
Financing Activities
Debt Repaid----------$78K$3.07M$1.26M-$2.63M
Common Stock Issuance$110.45M$6.91M$30.23M$648K$107.71M$11.29M$0$134.6M$19.96M$159K$81.78M$0$0
Common Stock Repurchases$0$0$0$0$0$0$0$0$0$0$0$0$0
Dividends Paid$0$0$0$0$0$0$0$0$0$0-$6.71M$0$0
Other Financing Activities$0$613K$0$0$2.5M$5.61M$1.63M$5.03M$3.84M$918K$6.97M$8K$62K
Net Cash from Financing$110.45M$7.52M$30.23M$648K$110.21M$16.89M$1.63M$139.62M$23.8M$996K$153.4M$25.55M$2.7M
Forex Effect$0$0$0$0$0$0$0$0$0$0$0$0$0
Net Change in Cash-$24.89M$20.99M-$176.48M-$11.88M$13.67M$3.43M-$59.15M$70.03M$72.9M$44.82M-$4.57M$55.69M-$6.04M
Supplementary Data
Operating Cash Flow-$75.59M-$86.23M-$56.03M-$110.79M-$119.03M$5.26M-$140.48M-$75.52M$170.37M-$2.03M-$27.41M$31.8M-$8.01M
Capital Expenditure-$220K-$310K-$840K-$1.74M-$1.61M-$2.31M-$3.5M-$3.79M-$1.56M-$2.18M-$1.59M-$1.66M-$732K
Free Cash Flow-$75.81M-$86.54M-$56.88M-$112.53M-$120.64M$2.95M-$143.98M-$79.31M$168.81M-$4.21M-$29.01M$30.14M-$8.74M
Cash at Beginning$39.08M$18.09M$193.65M$206.45M$192.78M$189.34M$248.49M$178.47M$104.64M$59.82M$64.4M$8.7M$14.75M
Cash at End$14.19M$39.08M$17.17M$194.57M$206.45M$192.78M$189.34M$248.49M$177.55M$104.64M$59.82M$64.4M$8.7M